Analyst Ranking
Bottom 1%
#5096 out of 5134 analysts
Average Return
-10.05%
Win Rate
32%63 out of 195
Risk vs Reward
Poor
Good

Michael Petusky's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lifecore Biomedical IncLFCR
+131.94%$3.10$7.19
2023-03-19 -
2024-03-19
Buy
Haemonetics CorpHAE
+65.73%$50.65$83.94
2025-09-22 -
2025-12-05
Buy
Opko Health IncOPK
+65.31%$0.99$1.63
2024-02-27 -
2025-02-27
Buy
Haemonetics CorpHAE
+63.98%$51.19$83.94
2025-10-20 -
2025-12-05
Buy
Haemonetics CorpHAE
+55.47%$53.99$83.94
2025-08-07 -
2025-12-05
Buy

Michael Petusky Analyst Color

Get additional color on Michael Petusky's coverage of popular stocks

Michael Petusky's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Merit Medical Systems IncMMSI
25Buy$106.00+27.05%Maintains
23 days ago
Dentsply Sirona IncXRAY
20Buy$14.00+24.44%Maintains
a month ago
Haemonetics CorpHAE
22Buy$90.00+7.22%Maintains
a month ago
Anika Therapeutics IncANIK
15Buy$16.00+66.67%Maintains
a month ago
Henry Schein IncHSIC
18Buy$79.00+7.31%Maintains
a month ago
Orthofix Medical IncOFIX
4Buy$18.00+13.21%Maintains
a month ago
Option Care Health IncOPCH
18Buy$38.00+27.13%Maintains
a month ago
Opko Health IncOPK
11Buy$2.25+67.91%Maintains
a month ago
U S Physical Therapy IncUSPH
20Buy$103.00+37.28%Maintains
a month ago
Lemaitre Vascular IncLMAT
11Buy$95.00+12.39%Maintains
2 months ago
Verifyme IncVRME
10Buy$1.50+102.70%Maintains
4 months ago
Modivcare IncMODVQ
13Buy$6.00+2,027.66%Maintains
9 months ago
Surmodics IncSRDX
5Buy$71.00N/AMaintains
2 years ago
Lifecore Biomedical IncLFCR
9Buy$10.00N/AMaintains
2 years ago
Ati Physical Therapy IncATIP
1Buy$14.00N/AInitiates Coverage On
4 years ago
Pharmerica CorpPMC
1SellN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.